Introduction Resolys Bio is a biotechnology company that specializes in creating therapeutic agents for various acute and chronic conditions. The company's primary focus is on developing treatments for traumatic brain injury (TBI) and chronic tissue disorders, including joint hypermobility syndromes (JHS), lupus, rheumatoid arthritis, and fibromyalgia. Through its drug development programs, Resolys Bio aims to provide clinicians with effective tools to improve patient outcomes. |